West Pharmaceutical Services Inc (WST)
360.24
-7.94
(-2.16%)
USD |
NYSE |
Apr 26, 16:00
360.24
0.00 (0.00%)
After-Hours: 20:00
West Pharmaceutical Services Research and Development Expense (Quarterly): 18.40M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 18.40M |
September 30, 2023 | 16.40M |
June 30, 2023 | 16.50M |
March 31, 2023 | 17.10M |
December 31, 2022 | 15.90M |
September 30, 2022 | 13.60M |
June 30, 2022 | 14.40M |
March 31, 2022 | 14.60M |
December 31, 2021 | 13.70M |
September 30, 2021 | 13.10M |
June 30, 2021 | 13.80M |
March 31, 2021 | 12.20M |
December 31, 2020 | 12.90M |
September 30, 2020 | 12.50M |
June 30, 2020 | 10.80M |
March 31, 2020 | 10.70M |
December 31, 2019 | 10.20M |
September 30, 2019 | 9.30M |
June 30, 2019 | 9.60M |
March 31, 2019 | 9.80M |
December 31, 2018 | 9.80M |
September 30, 2018 | 10.10M |
June 30, 2018 | 10.80M |
March 31, 2018 | 9.60M |
December 31, 2017 | 9.70M |
Date | Value |
---|---|
September 30, 2017 | 9.10M |
June 30, 2017 | 10.00M |
March 31, 2017 | 10.30M |
December 31, 2016 | 9.60M |
September 30, 2016 | 9.00M |
June 30, 2016 | 8.80M |
March 31, 2016 | 9.40M |
December 31, 2015 | 10.00M |
September 30, 2015 | 8.50M |
June 30, 2015 | 8.10M |
March 31, 2015 | 7.50M |
December 31, 2014 | 7.80M |
September 30, 2014 | 10.80M |
June 30, 2014 | 9.90M |
March 31, 2014 | 10.00M |
December 31, 2013 | 9.70M |
September 30, 2013 | 9.60M |
June 30, 2013 | 9.50M |
March 31, 2013 | 9.10M |
December 31, 2012 | 8.60M |
September 30, 2012 | 8.20M |
June 30, 2012 | 8.20M |
March 31, 2012 | 8.30M |
December 31, 2011 | 7.20M |
September 30, 2011 | 7.70M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
9.30M
Minimum
Sep 2019
18.40M
Maximum
Dec 2023
13.46M
Average
13.60M
Median
Sep 2022
Research and Development Expense (Quarterly) Benchmarks
Becton Dickinson & Co | 290.00M |
Abbott Laboratories | 684.00M |
Masimo Corp | 38.00M |
Merit Medical Systems Inc | 21.64M |
Insulet Corp | 42.00M |